This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Equine Interferon Beta (IFNb), N-His-GST
Product Overview
BioVenic's Recombinant Equine Interferon Beta (IFNb), N-His-GST is a recombinant protein expressed from E.coli expression system. Its predicted molecular weight is 49.5 kDa. The purity is greater than 90% (SDS-PAGE). The endotoxin level is <1 EU/μg (LAL). It can be used as a positive control or as an immunogen.
Specifications
Target Information
In horses, the interferon beta protein is encoded by the IFNB1 gene. The mechanism of action of interferon-beta seems to be multifaceted, as it appears to influence the immune system at various levels. Interferon-beta has been observed to impact antigen-presenting cells, T cells, and B cells, suggesting a broad regulatory role in the immune response.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store for 4 weeks at 2-8°C, for 12 months at -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Aliquote the reconstituted solution to minimise freeze-thaw cycles.